Dieta cetogénica en cáncer: revisión de la literatura

Karolina Alvarez-Altamirano; Mónica Patricia Bejarano-Rosales; Erika Areli Rosas-Gonzalez; Karina Miramontes-Balcón; Alberto Serrano-Olvera; Vanessa Fuchs-Tarlovksy

doi:10.35454/rncm.v3n2.168

Autores/as

Karolina Alvarez-Altamirano Servicio de Nutrición Clínica, Hospital General de México “Dr Eduardo Liceaga”, México
Mónica Patricia Bejarano-Rosales Servicio de Nutrición Clínica, Hospital General de México “Dr Eduardo Liceaga”, México.
Erika Areli Rosas-Gonzalez Hospital General de México “Dr Eduardo Liceaga”, México.
Karina Miramontes-Balcón Servicio de Nutrición Clínica, Hospital General de Ciudad Juárez, México.
Alberto Serrano-Olvera Centro Médico, ABC, campus observatorio. México
Vanessa Fuchs-Tarlovksy Hospital General de México

DOI:

https://doi.org/10.35454/rncm.v3n2.168

Palabras clave:

Dieta cetog´énica, Neoplasias, Metabolismo

Resumen

El cáncer es una problemática de salud pública en el ámbito mundial. El impacto e la dieta sobre el crecimiento y la proliferación tumoral es un área importante de investigación. Las alteraciones propias del metabolismo glucídico en las células con cáncer incluyen la elevación de la dependencia de glucosa y la generación de energía a partir de un proceso anaeróbico. La disminución de la disponibilidad de glucosa en estas células a partir de la dieta surge como alternativa terapéutica para mejorar el curso clínico de pacientes con cáncer. La dieta cetogénica mimetiza los efectos metabólicos del ayuno limitando la disponibilidad de glucosa en el cuerpo; y por lo tanto, podría ser considerada una alternativa viable para mejorar el tratamiento y pronóstico del cáncer.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49(Suppl 8):3–5. doi: https://doi.org/10.1111/j.1528-1167.2008.01821.x.

Geyelin HR. Fasting as a method for treating epilepsy. Med Rec. 1921. 99:1037–9.

Peterman MG. The ketogenic diet in epilepsy. JAMA: The Journal of the American Medical Association. 1979;84(26). doi:10.1001/jama.1925.02660520007003.

Warburg O, Dickens F. The metabolism of tumors. Publisher: Constable, London, 1930.

Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144(5):646-74. doi: https://doi.org/10.1016/j.cell.2011.02.013.

Sremanakova J, Sowerbutts AM, Burden S. A systematic review of the use of ketogenic diets in adult patients with cancer. J Hum Nutr Diet. 2018; 31(6):793-802. doi: https://doi.org/10.1111/jhn.12587.

Weber DD, Aminazdeh-Gohari S, Kofler B. Ketogenic diet in cancer therapy. Aging. 2018;10(2):164-5. doi: https://doi.org/10.18632/aging.101382.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36(1):11-48. doi:https://doi.org/10.1016/j.clnu.2016.07.015.

Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer–Where do we stand? Mol Metab. 2020; 33:102-21. doi: https://doi.org/10.18632/aging.101382.

Zupec-Kania BA, Spellman E. An Overview of the Ketogenic Diet for Pediatric Epilepsy. Nutr Clin Pract. 2008; 23(6):589-96. doi: https://doi.org/10.1177/0884533608326138.

Kossoff EH, Wang HS. Dietary Therapies for Epilepsy. Biomed J. 2013;36(1):2-8. doi: https://doi.org/10.4103/2319-4170.107152.

Kossoff EH, Dorward JL. The Modified Atkins Diet. Epilepsia. 2008; 49(Suppl. 8):37-41. doi: https://doi.org/ 10.1111/j.1528-1167.2008.01831.x.

Klement RJ, Kämmerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab. 2011;8(1):75. doi: https://doi.org/10.1186/1743-7075-8-75.

Herrera-González NE, Martínez-García F, Mejía-Jiménez E. El efecto Warburg: la mano derecha en el desarrollo del cáncer. Rev Esp Méd Quir. 2015; 20(2):171-7.

Adekola K, Rosen ST, Shanmugam M. Glucose transporters in cancer metabolism. Curr Opin Oncol. 2012; 24(6):650-4. doi: https://doi.org/10.1097/CCO.0b013e328356da72.

Buettner GR. Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem. 2011;11(4):341–6. doi: https://doi.org/10.2174/187152011795677544.

Hegedűs C, Kovács K, Polgár Z, Regdon Z, Szabó É , Robaszkiewicz A, et al. Redox control of cancer cell destruction. Redox Biol. 2018;16:59-74. doi: https://doi.org/10.1016/j.redox.2018.01.015.

Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019; 22(2):129-34. doi: https://doi.org/10.1097/MCO.0000000000000540.

Glew RH. You can get there from here: acetone, anionic ketones and even-carbon fatty acids can provide substrates for gluconeogenesis. Niger J Physiol Sci. 2010; 25(1):2-4.

Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):309-19. doi: https://doi.org/10.1016/j.plefa.2003.09.007.

Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Müller-Fielitz H, et al. The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nature Commun. 2014; 5:3944. doi: https://doi.org/10.1038/ncomms4944.

Goncalves MD, Hopkins BD, Cantley LC. Phosphatidylinositol 3-kinase, growth disorders, and cancer. N Engl J Med. 2018;379(21):2052–62. doi: https://doi.org/10.1056/NEJMra1704560.

Yin C, Qiea S, Sang N. Carbon Source Metabolism and Its Regulation in Cancer Cells. Crit Rev Eukaryot Gene Expr. 2012;22(1):17–35. doi: https://doi.org/10.1615/critreveukargeneexpr.v22.i1.20.

Ristic B, Bhutia YD, Ganapathy V. Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer. Biochim Biophys Acta Rev Cancer. 2017;1868(1):246–57. doi: https://doi.org/10.1016/j.bbcan.2017.05.003.

Woolf EC, Curley KL, Liu Q, Turner GH, Charlton JA, Preul MC, et al. The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One. 2015; 10(6): e0130357. doi: https://doi.org/10.1371/journal.pone.0130357.

Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014;2:18. doi: https://doi.org/10.1186/2049-3002-2-18.

Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer. 1987; 56(1):39-43. doi: https://doi.org/10.1038/bjc.1987.149.

Beck SA, Tisdale MJ. Effect of insulin on weight loss and tumour growth in a cachexia model. Br J Cancer. 1989;59(5):677-81. doi: https://doi.org/10.1038/bjc.1989.140.

Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. Nutr Metab. 2010;7:33. doi: https://doi.org/10.1186/1743-7075-7-33.

Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab. 2011;8(1):54. doi: https://doi.org/10.1186/1743-7075-8-54.

Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol. 2014;44(6):1843-52. doi: https://doi.org/10.3892/ijo.2014.2382.

Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, et al. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol. 2014;117(1):125–31. doi: https://doi.org/ 10.1007/s11060-014-1362-0.

Branca JJV, Pacini S, Ruggiero M. Effects of Pre-surgical Vitamin D Supplementation and Ketogenic Diet in a Patient with Recurrent Breast Cancer. Anticancer Res. 2015;35(10):5525-32.

Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, et al. Modified Atkins diet in advanced malignancies–final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab. 2016;13:52. doi: https://doi.org/10.1186/s12986-016-0113-y.

Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Res Notes. 2016; 9:143. doi: https://doi.org/10.1186/s13104-016-1959-9.

Artzi M, Liberman G, Vaisman N, Bokstein F, Vitinshtein F, Aizenstein O, et al. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study. J Neurooncol. 2017;132(2):267–75. doi: https://doi.org/10.1007/s11060-016-2364-x.

Tóth C, Clemens Z. Treatment of Rectal Cancer with the Paleolithic Ketogenic Diet: A 24-months Follow-up. Am J Med Case Reports. 2017;5(8):205–16. doi: https://doi.org/10.12691/ajmcr-5-8-3.

Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath CA III, Huh WK, et al. A Ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. J Nutr. 2018;148(8):1253–60. doi: https://doi.org/10.1093/jn/nxy119.

de Groot S, Lugtenberg RT, Cohen D, Welters MJP, Ehsan I, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun. 2020; 3083. https://doi.org/10.1038/s41467-020-16138-3.